Search Results - "PLOG, Malinda S"

Enhanced efficacy of melanoma vaccines in the absence of B lymphocytes by PERRICONE, Michael A, SMITH, Karen A, CLAUSSEN, Kirsten A, PLOG, Malinda S, HEMPEL, Donna M, ROBERTS, Bruce L, ST. GEORGE, Judith A, KAPLAN, Johanne M

“…Provoking a specific cellular immune response against tumor-associated antigens is a promising therapeutic strategy to treat cancers with defined antigens such…”
Get full text

Preclinical safety and biodistribution of adenovirus-based cancer vaccines after intradermal delivery by Plog, Malinda S, Guyre, Cheryl A, Roberts, Bruce L, Goldberg, Mark, St George, Judith A, Perricone, Michael A

“…The recombinant adenoviral (Ad) vector is being considered as a cancer vaccine platform because it efficiently induces immune responses to tumor antigens by…”
Get more information

Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. II. Transfection efficiency in airway epithelium by Perricone, M A, Morris, J E, Pavelka, K, Plog, M S, O'Sullivan, B P, Joseph, P M, Dorkin, H, Lapey, A, Balfour, R, Meeker, D P, Smith, A E, Wadsworth, S C, St George, J A

“…A phase I clinical trial was conducted in which recombinant adenovirus containing the cystic fibrosis trans-membrane regulator (CFTR) (Ad2/CFTR) was…”
Get more information